Skip to main content
SpringerLink
Log in

NICE recommends ranibizumab for choroidal neovascularisation . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE gives green light to ranibizumab for eye condition in final draft guidance. Media Release : 24 Oct 2013. Available from: URL: http://www.nice.org.uk

  2. NICE. NICE consults on draft guidance recommending tests to help diagnose and treat asthma. Media Release : 6 Nov 2013. Available from: URL: http://www.nice.org.uk

  3. NICE. NICE requests more data on bortezomib for multiple myeloma. Media Release : 12 Nov 2013. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE recommends ranibizumab for choroidal neovascularisation . . .. PharmacoEcon Outcomes News 691, 11 (2013). https://doi.org/10.1007/s40274-013-0881-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0881-9

Search

Navigation